The Role of Liver Cancer Stem Cells in Donor Liver Allocation for Patients With Hepatocellular Carcinoma

References

• . Duffy JP, Vardanian A, Benjamin E, . Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg. 2007;246(3):502–509; discussion 509–511
   PubMed Web of Science ®Google Scholar
• . Mazzaferro V, Regalia E, Doci R, . Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–699
   PubMed Web of Science ®Google Scholar
• . Yao FY, Ferrell L, Bass NM, . Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33(6):1394–1403
   PubMed Web of Science ®Google Scholar
• . Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228(4):479–490
   PubMed Web of Science ®Google Scholar
• . Cillo U, Vitale A, Bassanello M, . Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg. 2004;239(2):150–159
   PubMed Web of Science ®Google Scholar
• . Iwatsuki S, Dvorchik I, Marsh JW, . Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191(4):389–394
   PubMedGoogle Scholar
• . Zheng SS, Xu X, Wu J, . Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation. 2008;85(12):1726–1732
   PubMed Web of Science ®Google Scholar
• . Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3(12):895–902
   PubMed Web of Science ®Google Scholar
• . Zeng Z, Ren J, O'Neil M, . Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation. BMC Cancer. 2012;12:584
   PubMed Web of Science ®Google Scholar
• . Yao FY, Ferrell L, Bass NM, . Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002;8(9):765–774
   PubMed Web of Science ®Google Scholar
• . Germani G, Gurusamy K, Garcovich M, . Which matters most: number of tumors, size of the largest tumor, or total tumor volume? Liver Transpl. 2011;17( Suppl 2):S58–S66
   PubMed Web of Science ®Google Scholar
• . Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30(6):1434–1440
   PubMed Web of Science ®Google Scholar
• . Okada S, Shimada K, Yamamoto J, . Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology. 1994;106(6):1618–1624
   PubMedGoogle Scholar
• . Shirabe K, Kanematsu T, Matsumata T, . Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology. 1991;14(5):802–805
   PubMedGoogle Scholar
• . Adachi E, Maeda T, Matsumata T, . Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995;108(3):768–775
   PubMedGoogle Scholar
• . Poon RT, Fan ST, Lo CM, . Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg. 1999;229(2):216–222
   PubMed Web of Science ®Google Scholar
• . Minagawa M, Makuuchi M, Takayama T, . Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg. 2003;238(5):703–710
   PubMed Web of Science ®Google Scholar
• . Nagasue N, Uchida M, Makino Y, . Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105(2):488–494
   PubMedGoogle Scholar
• . Wayne JD, Lauwers GY, Ikai I, . Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg. 2002;235(5):722–730; discussion 730–731
   PubMed Web of Science ®Google Scholar
• . Yang LY, Fang F, Ou DP, . Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009;249(1):118–123
   PubMed Web of Science ®Google Scholar
• . Nathan H, Schulick RD, Choti MA, . Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg. 2009;249(5):799–805
   PubMed Web of Science ®Google Scholar
• . Merani S, Majno P, Kneteman NM, . The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. J Hepatol. 2011;55(4):814–819
   PubMed Web of Science ®Google Scholar
• . Ochiai T, Sonoyama T, Ichikawa D, . Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol. 2004;130(4):197–202
   PubMedGoogle Scholar
• . De Carlis L, Giacomoni A, Pirotta V, . Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg. 2003;196(6):887–897
   PubMedGoogle Scholar
• . Toso C, Asthana S, Bigam DL, . Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology. 2009;49(3):832–838
   PubMed Web of Science ®Google Scholar
• . Lei J, Yan L. Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies. J Gastrointest Surg. 2013;17(6):1116–1122
   PubMedGoogle Scholar
• . Audet M, Panaro F, Piardi T, . Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries? Liver Transpl. 2009;15(7):822–823; author reply 824–826
   PubMedGoogle Scholar
• . Sato Y, Sekine T, Ohwada S. Alpha-fetoprotein-producing rectal cancer: calculated tumor marker doubling time. J Surg Oncol. 1994;55(4):265–268
   PubMedGoogle Scholar
• . Adachi Y, Tsuchihashi J, Shiraishi N, . AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology. 2003;65(2):95–101
   PubMed Web of Science ®Google Scholar
• . Marrero JA, Fontana RJ, Barrat A, . Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology. 2005;41(4):707–716
   PubMed Web of Science ®Google Scholar
• . Trevisani F, DTntino PE, Morselli-Labate AM, . Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol. 2001;34(4):570–575
   PubMed Web of Science ®Google Scholar
• . Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology. 2008;48(6):2047–2063
   PubMed Web of Science ®Google Scholar
• . Iizuka N, Oka M, Yamada-Okabe H, . Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet. 2003;361(9361):923–929
   PubMed Web of Science ®Google Scholar
• . Ye QH, Qin LX, Forgues M, . Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med. 2003:9(4):416–423
   PubMed Web of Science ®Google Scholar
• . Smith MW, Yue ZN, Geiss GK, . Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res. 2003;63(4):859–864
   PubMed Web of Science ®Google Scholar
• . Villanueva A, Hoshida Y, Toffanin S, . New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res. 2010;16(19):4688–4694
   PubMed Web of Science ®Google Scholar
• . Li R, Qian N, Tao K, . MicroRNAs involved in neoplastic transformation of liver cancer stem cells. J Exp Clin Cancer Res. 2010;29:169
   PubMed Web of Science ®Google Scholar
• . Miraglia S, Godfrey W, Yin AH, . A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1997;90(12):5013–5021
   PubMed Web of Science ®Google Scholar
• . Suetsugu A, Nagaki M, Aoki H, . Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun. 2006;351(4):820–824
   PubMed Web of Science ®Google Scholar
• . Yin S, Li J, Hu C, . CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer. 2007;120(7):1444–1450
   PubMed Web of Science ®Google Scholar
• . Chiba T, Kita K, Zheng YW, . Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006;44(1):240–251
   PubMed Web of Science ®Google Scholar
• . Zhang C, Xu Y, Zhao J, . Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma. Ann Surg Oncol. 2011;18(8):2373–2380
   PubMedGoogle Scholar
• . Tang KH, Ma S, Lee TK, . CD 133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology. 2012;55(3):807–820
   PubMed Web of Science ®Google Scholar
• . Song W, Li H, Tao K, . Expression and clinical significance of the stem cell marker CD 133 in hepatocellular carcinoma. Int J Clin Pract. 2008;62(8):1212–1218
   PubMed Web of Science ®Google Scholar
• . Ma S, Tang KH, Chan YP, . miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell. 2010;7(6):694–707
   PubMed Web of Science ®Google Scholar
• . Ma YC, Yang JY, Yan LN. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol. 2013. doi:10.1097/MEG.0b013e32836019d8
   Google Scholar
• . Rege TA, Hagood JS. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 2006;20(8):1045–1054
   PubMedGoogle Scholar
• . Yang ZF, Ngai P, Ho DW, . Identification of local and circulating cancer stem cells in human liver cancer. Hepatology. 2008;47(3):919–928
   PubMed Web of Science ®Google Scholar
• . Yang ZF, Ho DW, Ng MN, . Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008;13(2):153–166
   PubMed Web of Science ®Google Scholar
• . Yamashita T, Honda M, Nakamoto Y, . Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology. 2013;57(4):1484–1497
   PubMed Web of Science ®Google Scholar